These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6851625)

  • 41. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Pharmacokinetics of indomethacin.
    Helleberg L
    Clin Pharmacokinet; 1981; 6(4):245-58. PubMed ID: 7249487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies of pharmacokinetics of indomethacin in man under consideration of bioavailability.
    Hippius M; Reinicke C
    Agents Actions Suppl; 1982; 10():109-17. PubMed ID: 6956211
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacokinetics and tolerance of slow-release indomethacin tablets in rheumatoid arthritis.
    Kaarela K; Lehtinen K; Mäkisara P; Holttinen K; Lamminsivu U; Gordin A
    Eur J Clin Pharmacol; 1982 Oct; 23(4):349-51. PubMed ID: 7173304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories.
    Jensen KM; Grenabo L
    Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):322-7. PubMed ID: 4090993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on the bioavailability of sustained-release indomethacin capsules].
    Li D; Yang XY; Wang JP; Wang YM; Shan J; Zhang HL; Bai YZ; Tao XH; Mo SY
    Yao Xue Xue Bao; 1985 May; 20(5):387-91. PubMed ID: 4083026
    [No Abstract]   [Full Text] [Related]  

  • 47. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
    Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
    Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zidometacin: pharmacokinetic study on oral absorption.
    Bonardi G; Colombo F; Guenzati G; Lepore AM; Sega R
    Int J Clin Pharmacol Res; 1984; 4(6):419-23. PubMed ID: 6533086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioavailability of indomethacin capsules in humans. (I): Bioavailability and effects of gastric acidity.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):469-74. PubMed ID: 4055157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nifedipine gastrointestinal therapeutic system.
    Swanson DR; Barclay BL; Wong PS; Theeuwes F
    Am J Med; 1987 Dec; 83(6B):3-9. PubMed ID: 3503595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlling drug effects through improved oral formulations. The pharmacokinetics of the prazosin gastrointestinal therapeutic system.
    DiPiro JT
    Am J Med; 1989 Aug; 87(2A):31S-35S. PubMed ID: 2764016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A new dosage form of indomethacin. Pharmaceutical profile of an oral form with osmotically controlled release].
    Helfand WH; Pejouan BL
    Ann Pharm Fr; 1983; 41(5):401-8. PubMed ID: 6675502
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral osmotically driven systems: 30 years of development and clinical use.
    Malaterre V; Ogorka J; Loggia N; Gurny R
    Eur J Pharm Biopharm; 2009 Nov; 73(3):311-23. PubMed ID: 19602438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of blood loss caused by two prolonged-release formulations of indomethacin ('Flexin Continus' and 'Indocid' R) in normal healthy male volunteers.
    Bird HA; Hill J; Ardley RG; McEvoy M; Wright V
    Curr Med Res Opin; 1988; 11(1):4-9. PubMed ID: 3260167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin.
    Sugihara H; Yamamoto H; Kawashima Y; Takeuchi H
    J Liposome Res; 2012 Mar; 22(1):72-9. PubMed ID: 22329417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of a sustained-release product of indomethacin in the elderly.
    Bruguerolle B; Barbeau G; Bélanger PM; Labrecque G
    Gerontology; 1986; 32(5):277-85. PubMed ID: 3569930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of oral and intravenous indomethacin in preterm infants.
    Bhat R; Vidyasagar D; Fisher E; Hastreiter A; Ramirez JL; Burns L; Evans M
    Dev Pharmacol Ther; 1980; 1(2-3):101-10. PubMed ID: 6927543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What's new in Osmosin and intestinal perforation?
    Laidler P; Maslin SC; Gilhome RW
    Pathol Res Pract; 1985 Jul; 180(1):74-6. PubMed ID: 4034434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elementary osmotic pump for indomethacin.
    Theeuwes F; Swanson D; Wong P; Bonsen P; Place V; Heimlich K; Kwan KC
    J Pharm Sci; 1983 Mar; 72(3):253-8. PubMed ID: 6842377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.